|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017296,
umls-concept:C0017337,
umls-concept:C0027651,
umls-concept:C0030705,
umls-concept:C0205221,
umls-concept:C0205349,
umls-concept:C0205395,
umls-concept:C0280100,
umls-concept:C1418515,
umls-concept:C1510986,
umls-concept:C1519043
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-12-15
|
|
pubmed:abstractText |
The use of genetically modified autologous tumor cells appears to be a promising approach for cancer therapy. A phase I/II trial was undertaken to define the feasibility, safety and antitumor effects of the autologous vaccine prepared by transferring tag7/PGRP-S gene into malignant melanoma and renal cell carcinoma cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:AnisimovV VVV,
pubmed-author:BalduevaI AIA,
pubmed-author:BarchukA SAS,
pubmed-author:DanilovA OAO,
pubmed-author:DanilovaA BAB,
pubmed-author:GaftonG IGI,
pubmed-author:GeorgievG PGP,
pubmed-author:HansonK PKP,
pubmed-author:KanaevS VSV,
pubmed-author:KiselevS LSL,
pubmed-author:KochnevV AVA,
pubmed-author:LargeS LSL,
pubmed-author:MoiseyenkoV MVM,
pubmed-author:OrlovaR VRV,
pubmed-author:SemenovaA IAI,
pubmed-author:ShchekinaL ALA,
pubmed-author:TyukavinaN VNV
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
162-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15598955-Adult,
pubmed-meshheading:15598955-Aged,
pubmed-meshheading:15598955-Cancer Vaccines,
pubmed-meshheading:15598955-Carcinoma, Renal Cell,
pubmed-meshheading:15598955-Cytokines,
pubmed-meshheading:15598955-Female,
pubmed-meshheading:15598955-Gene Therapy,
pubmed-meshheading:15598955-Gene Transfer Techniques,
pubmed-meshheading:15598955-Humans,
pubmed-meshheading:15598955-Kidney Neoplasms,
pubmed-meshheading:15598955-Male,
pubmed-meshheading:15598955-Melanoma,
pubmed-meshheading:15598955-Middle Aged,
pubmed-meshheading:15598955-Skin Neoplasms,
pubmed-meshheading:15598955-Transfection,
pubmed-meshheading:15598955-Treatment Outcome,
pubmed-meshheading:15598955-Tumor Cells, Cultured
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Phase I/II trial of gene therapy with autologous tumor cells modified with tag7/PGRP-S gene in patients with disseminated solid tumors: miscellaneous tumors.
|
|
pubmed:affiliation |
N.N. Petrov Research Institute of Oncology, St Petersburg, Russian Federation.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
